Pfizer Limited - Asset Resilience Ratio

Latest as of March 2024: 93.68%

Pfizer Limited (PFIZER) has an Asset Resilience Ratio of 93.68% as of March 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Pfizer Limited balance sheet liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

Rs39.61 Billion

≈ $428.40 Million USD Cash + Short-term Investments

Total Assets

Rs42.29 Billion

≈ $457.33 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2005–2025)

This chart shows how Pfizer Limited's Asset Resilience Ratio has changed over time. See Pfizer Limited (PFIZER) shareholders funds for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Pfizer Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Pfizer Limited.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs20.47 Billion	48.4%
Short-term Investments	Rs19.15 Billion	45.28%
Total Liquid Assets	Rs39.61 Billion	93.68%

Asset Resilience Insights

Very High Liquidity: Pfizer Limited maintains exceptional liquid asset reserves at 93.68% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Pfizer Limited Industry Peers by Asset Resilience Ratio

Compare Pfizer Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
AbbVie Inc NYSE:ABBV	Drug Manufacturers - General	0.02%
Roche Holding AG SW:ROG	Drug Manufacturers - General	15.37%
Biogen Inc NASDAQ:BIIB	Drug Manufacturers - General	2.74%
CSPC Pharmaceutical Group Limited F:CVG	Drug Manufacturers - General	4.64%
AstraZeneca PLC LSE:AZN	Drug Manufacturers - General	0.03%
Yifan Xinfu Pharmaceutical Co Ltd SHE:002019	Drug Manufacturers - General	0.53%
Hubei Guangji Pharmaceutical Co Ltd SHE:000952	Drug Manufacturers - General	5.37%
Dimed S.A. Distribuidora de Medicamentos SA:PNVL3	Drug Manufacturers - General	10.10%

Annual Asset Resilience Ratio for Pfizer Limited (2005–2025)

The table below shows the annual Asset Resilience Ratio data for Pfizer Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	56.62%	Rs27.81 Billion ≈ $300.72 Million	Rs49.11 Billion ≈ $531.12 Million	+8.80pp
2024-03-31	47.82%	Rs20.22 Billion ≈ $218.70 Million	Rs42.29 Billion ≈ $457.33 Million	+2.04pp
2023-03-31	45.79%	Rs18.32 Billion ≈ $198.10 Million	Rs40.01 Billion ≈ $432.66 Million	+5.25pp
2022-03-31	40.54%	Rs15.81 Billion ≈ $171.01 Million	Rs39.01 Billion ≈ $421.83 Million	+8.66pp
2021-03-31	31.88%	Rs10.41 Billion ≈ $112.59 Million	Rs32.66 Billion ≈ $353.19 Million	-17.70pp
2020-03-31	49.58%	Rs21.84 Billion ≈ $236.21 Million	Rs44.05 Billion ≈ $476.43 Million	+2.02pp
2019-03-31	47.55%	Rs18.74 Billion ≈ $202.63 Million	Rs39.40 Billion ≈ $426.09 Million	+0.81pp
2018-03-31	46.75%	Rs17.25 Billion ≈ $186.56 Million	Rs36.90 Billion ≈ $399.06 Million	+1.28pp
2017-03-31	45.47%	Rs14.87 Billion ≈ $160.81 Million	Rs32.71 Billion ≈ $353.71 Million	+45.32pp
2016-03-31	0.15%	Rs43.26 Million ≈ $467.81K	Rs29.14 Billion ≈ $315.11 Million	+0.15pp
2012-03-31	0.00%	Rs500.00K ≈ $5.41K	Rs15.76 Billion ≈ $170.49 Million	-39.68pp
2011-03-31	39.68%	Rs5.50 Billion ≈ $59.49 Million	Rs13.86 Billion ≈ $149.92 Million	+8.76pp
2010-03-31	30.92%	Rs3.72 Billion ≈ $40.24 Million	Rs12.03 Billion ≈ $130.14 Million	+8.33pp
2009-03-31	22.59%	Rs2.48 Billion ≈ $26.82 Million	Rs10.98 Billion ≈ $118.71 Million	-30.54pp
2008-03-31	53.13%	Rs4.61 Billion ≈ $49.85 Million	Rs8.67 Billion ≈ $93.81 Million	+42.82pp
2007-03-31	10.31%	Rs666.73 Million ≈ $7.21 Million	Rs6.47 Billion ≈ $69.92 Million	-1.16pp
2006-03-31	11.47%	Rs660.82 Million ≈ $7.15 Million	Rs5.76 Billion ≈ $62.30 Million	-1.92pp
2005-03-31	13.39%	Rs699.09 Million ≈ $7.56 Million	Rs5.22 Billion ≈ $56.47 Million	--

pp = percentage points

About Pfizer Limited

NSE:PFIZER India Drug Manufacturers - General

Market Cap

$2.33 Billion

Rs215.50 Billion INR

Market Cap Rank

#5706 Global

#246 in India

Share Price

Rs4710.60

Change (1 day)

-1.10%

52-Week Range

Rs4243.60 - Rs5889.00

All Time High

Rs6318.30